Table 2. Discrimination of healthy controls from HPV-negative HNSCC patients and -positive HNSCC patients using the combined miRNA panels.

	Control vs HPV-patients	Control vs HPV +patients
Probability threshold	0.45	0.41
Sensitivity	0.60	0.65
Specificity	0.94	0.95
Negative predictive value	0.85	0.85
Positive predictive value	0.82	0.87
AUC	0.82	0.80